n-3 fatty acids and human hypertension.
Clinical studies of the antihypertensive effects of n-3 fatty acids in different groups of patients are summarized, and recent information of possible mechanisms of antihypertensive effects is discussed. Because of marked differences between fatty acid metabolism and blood pressure control of humans and laboratory animals, the focus is on human studies.
Knapp
H R
HR
UIHC, Internal Medicine, Iowa City 52242-1083, USA.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications; D001794:Blood Pressure / Q000187:drug effects; D018849:Controlled Clinical Trials as Topic; D016572:Cyclosporine / Q000009:adverse effects; D048909:Diabetes Complications; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000150:complications / Q000517:prevention & control*
D000959:Antihypertensive Agents; D015525:Fatty Acids, Omega-3; D016572:Cyclosporine